ADIL MED LTD
Opportunity 73/100 (strong), bankability 75/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (76/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · accounting standard unknown| Metric | 2025-08-31 | 2024-08-31 |
|---|
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 accounts
- • 1 accounts
- • 1 accounts
Corporate timeline (18 events)Click to expand
- 2026-05-12📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2025-03-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2024-04-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-12-22📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2021-11-01📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2020-10-20📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2019-11-26📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2018-12-03📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2018-10-19📄change-person-director-company-with-change-dateofficers · CH01
- 2018-10-19📄change-person-secretary-company-with-change-dateofficers · CH03
- 2018-10-19📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2018-10-16📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC01
- 2018-10-16📄withdrawal-of-a-person-with-significant-control-statementpersons-with-significant-control · PSC09
- 2017-11-22📄accounts-with-accounts-type-unaudited-abridgedaccounts · AA
- 2016-12-09📄accounts-with-accounts-type-total-exemption-smallaccounts · AA
- 2015-08-12🏢Company incorporatedAs ADIL MED LTD
- 2015-08-12➕AMINI, Mohammad Adil appointedsecretary
- 2015-08-12➕AMINI, Mohammad Adil appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +No director turnover: Company is 11 years old with no director changes — suggests a very tight-knit founder team never broadened.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanShareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Mr Mohammad Adil Amini Individual · British · DOB 03/1990 · age 36 | — | — | sig. influencesignificant influence | 16/10/2018 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Similar companies
Active · Healthcare & medical · BD postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| 2020 VISION LIMITED→ 16267111 · est 2025 · no financials extracted | — | — | — | — | 1y | — | — |
| A HIJAMA CUPPING LIMITED→ 14983490 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| A.A CARE LTD→ 13385369 · est 2021 · no financials extracted | — | — | — | — | 4y | — | — |
| A&H LOCUM LIMITED→ 14523452 · est 2022 · no financials extracted | — | — | — | — | 3y | — | — |
| AA PHYSIO LIMITED→ 15720070 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| AAMANAH CARE SERVICES LTD→ 16946633 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ACMT SURGERY LIMITED→ 07857738 · est 2011 · no financials extracted | — | — | — | — | 14y | — | — |
| ACTION FOR SPORT→ 11883782 · est 2019 · no financials extracted | — | — | — | — | 7y | — | — |
| ACTIVATE MEDICALS LIMITED→ 14719108 · est 2023 · no financials extracted | — | — | — | — | 3y | — | — |
| ACUITY OPTICAL LTD→ 15055923 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADIL PHARMA LIMITED→ 13873606 · est 2022 · no financials extracted | — | — | — | — | 4y | — | — |
| ADNAN LOCUMS LIMITED→ 10848416 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (2 active · 0 resigned)
Click a director name to see their full track record across all companies.